Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Industry News

February 9, 2010
Azopharma Drug Development Services has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for production of commercial product.   Read More »

February 9, 2010
Tysabri revenues in the quarter increased 39% to $216 million and Avonex revenues were up 5% to $596 million.   Read More »

February 9, 2010
Development segment revenue in the quarter was $328.1 million (-3%) and for the year was $1.3 billion (-8%).  Read More »

February 8, 2010
Teva Pharmaceutical Industries, Ltd. and Active Biotech have amended their marketing and distribution agreement for oral laquinimod, an investigational drug for relapsing-remitting multiple sclerosis (RRMS).  Read More »

February 8, 2010
NextPharma has appointed a new management team at its San Diego, CA facility.   Read More »

February 8, 2010
Talecris Biotherapeutics’ aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency, was granted orphan drug designation by the FDA.  Read More »

February 5, 2010
Scott Canute has joined Genzyme as head of manufacturing and corporate operations.   Read More »

February 5, 2010
Analytical Bio-Chemistry Laboratories (ABC) has expanded its capabilities to include comprehensive support for large molecule development.  Read More »

February 5, 2010
Gorbec Pharmaceutical Services is opening a GMP-compliant analytical lab in Yantai, China.  Read More »

February 5, 2010
Alison Bond, Ph.D. has been appointed to lead Quanticate’s new Pharmacovigilance Services team.   Read More »

February 5, 2010
Criterium, Inc., a full-service CRO, has expanded its staff in the U.S., India and South Africa as part its business plan to increase capabilities, accommodate current sponsors and project deliverables, as well as conduct trials in a wider range of areas   Read More »

February 4, 2010
Vaccine sales were up 85% to $2.4 billion with flu pre-pandemic sales accounting for $1.3 billion in the quarter.  Read More »

February 4, 2010
Specialty pharmaceuticals sales were up 18% to $995 million in the quarter, and for the year sales were up 5% to $3.7 billion.   Read More »

February 4, 2010
Growth in the quarter was driven by an increase in Specialty Injectable Pharmaceuticals, with sales in the Americas up 27% to $439.2 million, in Europe, Middle East & Africa, sales were $76.7 million (+21%), and in the Asia Pacific region, sales were   Read More »

February 4, 2010
Steve Meeker has been appointed vice president of manufacturing operations and head of U.S. operations at Bayer HealthCare’s manufacturing facility in Shawnee, KS.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On